Comparison of Keppra and Clonidine in the Treatment of Tics
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to confirm that levetiracetam has a better tic-suppressing profile
than that of the widely used tic-suppressing medication, clonidine. More specifically, the
investigators hypothesize that in a 15 week placebo run-in, double-blind, medication
cross-over trial; levetiracetam will be more effective and have fewer side-effects than
clonidine.